In addition, as we previously found that the non-receptor tyrosine kinase Src promotes the secretion of cancer-derived exosomes and the broad tyrosine kinase inhibitor dasatinib effectively suppresses exosome secretion31. This evidence concerns the gene SRC and cancer.